1,160 results on '"Albanese, Alberto"'
Search Results
2. Tauro-Urso-Deoxycholic Acid Trials in Amyotrophic Lateral Sclerosis: What is Achieved and What to Expect
3. A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial
4. Duration of botulinum toxin efficacy in cervical dystonia clinical trials: A scoping review
5. Post-COVID parkinsonism: A scoping review
6. Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
7. Dystonic Tremor
8. Worldwide barriers to genetic testing for movement disorders
9. COVID-19-associated Guillain-Barré syndrome in the early pandemic experience in Lombardia (Italy)
10. Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial
11. Do cerebrovascular risk factors impact the clinical expression of idiopathic isolated adult-onset dystonia?
12. Do demographic and clinical features and comorbidities affect the risk of spread to an additional body site in functional motor disorders?
13. Causality or hazard in post-COVID parkinsonism?
14. Dystonic Tremor: Time to Change
15. Benefit of Repeated Injections of IncobotulinumtoxinA for Pain Reduction in Adults with Cervical Dystonia and Moderate or Severe Baseline Pain: An Analysis of Pooled Data (P8-3.004)
16. Prospective, Multicenter, International Registry of Deep Brain Stimulation for Dystonia: Sub-analysis of Cervical Dystonia Patients (P1-3.018)
17. 1137 Prospective, Multicenter, International Registry of Deep Brain Stimulation for Dystonia: A Sub-analysis of Cervical Dystonia Patients
18. Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
19. Does sex influence the natural history of idiopathic adult-onset dystonia?
20. Development of a patient journey map for people living with cervical dystonia
21. Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases
22. Eligibility criteria in clinical trials for cervical dystonia
23. Correction to: COVID‑19‑associated Guillain‑Barré syndrome in the early pandemic experience in Lombardia (Italy)
24. Functional motor phenotypes: to lump or to split?
25. Distribution of the C9orf72 hexanucleotide repeat expansion in healthy subjects: a multicenter study promoted by the Italian IRCCS network of neuroscience and neurorehabilitation
26. Pain Reduction in Adults With Cervical Dystonia Following a Single Injection of IncobotulinumtoxinA: A Pooled Analysis
27. Pain Reduction After Repeated Injections of IncobotulinumtoxinA for Pain Reduction in Adults With Cervical Dystonia and Moderate or Severe Baseline Pain
28. Duration of Botulinum Toxin Efficacy in Cervical Dystonia Clinical Trials: A Narrative Review
29. Benefit of Multiple IncobotulinumtoxinA Injections for Pain Reduction in Adults With Cervical Dystonia: An Analysis of Pooled Data
30. MRI abnormalities identify Neuronal Intranuclear Inclusion Disease (NIID)
31. Pain reduction in adults with cervical dystonia following a single injection of incobotulinumtoxina: A pooled analysis
32. Benefit of repeated injections of incobotulinumtoxina for pain reduction in adults with cervical dystonia and moderate or severe baseline pain: An analysis of pooled data
33. Benefit of multiple incobotulinumtoxina injections for pain reduction in adults with cervical dystonia: An analysis of pooled data
34. Spread of segmental/multifocal idiopathic adult-onset dystonia to a third body site
35. Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial
36. Adapting to post-COVID19 research in Parkinson's disease: Lessons from a multinational experience
37. A genome-wide association study in multiple system atrophy
38. The apparent paradox of phenotypic diversity and shared mechanisms across dystonia syndromes
39. Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort.
40. Parkinsonism and dysautonomia: Multiple system atrophy?
41. Elderly Onset of Functional Motor Disorders: Clinical Correlates from the Italian Registry
42. Do cerebrovascular risk factors impact the clinical expression of idiopathic isolated adult-onset dystonia?
43. Demographic and clinical determinants of neck pain in idiopathic cervical dystonia
44. Neurological features in SARS-CoV-2-infected patients with smell and taste disorder
45. Mitochondrial dysfunction in fibroblasts of Multiple System Atrophy
46. Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study
47. Harmonizing Genetic Testing for Parkinson's Disease: Results of the PARKNET Multicentric Study.
48. A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial
49. Case report: Atypical Parkinsonism following SARS-CoV-2 infection
50. Phenotypic Variability in Acquired and Idiopathic Dystonia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.